Shenzhen Rurisheng Equity Investment

Shenzhen Rurisheng Equity Investment

Shenzhen Rurisheng Equity Investment operates from the Xiangjiang Financial Building in Shenzhen's Nanshan District, a hub for China's technology sector. The firm is managed by Executive Director Zhang Wei, while Ju Hong serves as the sole shareholder. The firm's governance includes Supervisor Zhang Jing, completing a lean corporate structure typical of privately held Chinese investment entities. Rurisheng pursues a multi-stage strategy spanning seed, start-up, and expansion-stage deals. Its investment activity concentrates on enterprise software, healthcare services, AI/ML, and industrial technology. The firm co-invests alongside established regional players — public records show repeated participation in rounds with CDIB Capital International and SAIF Partners, two firms with deep networks across Greater China's venture ecosystem. The firm also maintains investment partnerships in Jiaxing and Nanjing, indicating a footprint that extends into key innovation corridors in Zhejiang and Jiangsu provinces. The firm's scale remains closely held. No assets under management or total deployment figures have been publicly disclosed. Its corporate filings list a real estate asset — an office unit in the Xiangjiang Financial Building — and two affiliated investment partnerships: Jiaxing Yongzhong Equity Investment Partnership and Nanjing Jinli Venture Investment Partnership. These entities likely serve as domestic RMB fund vehicles, a common structure for China-based managers who raise capital from local high-net-worth individuals and institutional investors. Rurisheng's structural differentiator lies in its philanthropic link to the University of Chinese Academy of Sciences Education Foundation. This relationship may provide proprietary access to deep-tech research and academic spinouts — a sourcing channel that distinguishes it from purely market-driven venture firms. The UCAS connection anchors the firm within China's elite scientific community, offering potential deal flow in frontier technology sectors that align with national research priorities.